The NLRP3 inflammasome is activated by a variety of pathways, which can upregulate the expression of IL-1β in pancreatic islets and adipose tissue, resulting in the development of T2DM [104–106]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.